Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure

Circulation Journal

Volumn 72, Issue 2, 2008, Pages 268-273

  Niwano, Shinichi ^a   Fukaya, Hidehira ^a   Yuge, Masaru ^a   Imaki, Ryuta ^a   Hirasawa, Shouji ^a   Sasaki, Takeshi ^a   Yumoto, Yoshihiro ^a   Inomata, Takayuki ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catheter ablation; Electrophysiologic study; Heart failure; Implantable cardioverter defibrillator; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER ABLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

AGED; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 40949092756     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.268     Document Type: Article

References (21)

1. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure: Results of the cooperative North Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
2. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325: 1468-1475.
3. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration cooperative study. N Engl J Med 1986; 314: 1547-1552.
4. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669-677.
5. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
6. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmia. N Engl J Med 1997; 337: 1576-1583.
7. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342: 1937-1945.
8. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigator. N Engl J Med 1996; 335: 1933-1940.
9. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
10. Niwano S, Yamaura M, Yoshizawa N, Moriguchi M, Kitano Y, Aizawa Y, et al. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study guided effective pharmacological therapy. Jpn Circ J 1999; 63: 674-680.
11. Josephson ME, Horowitz LN. Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia. Am J Cardiol 1979; 43: 631-642.
12. Wilber D, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, et al. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318: 19-24.
13. Yuge M, Niwano S, Moriguchi M, Sasaki T, Hirasawa S, Imaki R, et al. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia. Circ J 2006; 70: 268-272.
14. Niwano S, Furushima H, Taneda K, Abe A, Ohira K, Aizawa Y. The usefulness of hotter monitoring in selection of pharmacological therapy for patients with sustained ventricular tachycardia: Studies in patients with no effective pharmacological therapy determined in the electrophysiologic study. Jpn Circ J 1998; 62: 347-352.
15. Zipes DP, DiMarco JP, Gillette PC, Jackman WM, Myerburg RJ, Rahimtoola SH, et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995; 26: 555-573.
16. Waller TJ, Kay HR, Spielman SR, Kutalek SP, Greenspan AM, Horowitz LN. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmia. J Am Coll Cardiol 1987; 10: 83-89.
17. Mitchell LB, Sheldon RS, Gillis AM, Connolly SJ, Duff HJ, Gardner MJ, et al. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: Randomized comparison of patient response criteria. J Am Coll Cardiol 1997; 30: 1346-1353.
18. Savard P, Rouleau JL, Ferguson J, Poitras N, Morel P, Davies RF, et al. Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation 1997; 96: 202-213.
19. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Eng J Med 1994; 330: 235-241.
20. Karcz M, Chojnowska L, Zareba W, Ruzyllo W. Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol 2003; 87: 75-81.
21. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-484.